Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|October 22, 2025
Substitution of ifosfamide for cyclophosphamide in the TI-CE regimen: pharmacology and dose justification in a patient with refractory metastatic germ-cell tumor post-nephrectomy-A case reportLotte M G Hulskotte, Loek A W de Jong, Alwin D R Huitema, et al.
British Journal of Clinical Pharmacology|August 26, 2021
The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancerEmmy Boerrigter, Guillemette E Benoist, Joanneke K Overbeek, et al.
Therapeutic Advances in Medical Oncology|December 17, 2024
Circulating tumor DNA-guided treatment decision in metastatic castration-resistant prostate cancer patients: a cost-effectiveness analysisCatharina J P Op 't Hoog, Sabien J E Bosman, Emmy Boerrigter, et al.
Cancer Treatment Reviews|April 6, 2021
High-dose administration of tyrosine kinase inhibitors to improve clinical benefit: A systematic reviewSophie L Gerritse, Jorien B E Janssen, Mariette Labots, et al.
Drug Discovery Today|March 21, 2016
Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumorsAnnelieke E C A B Willemsen, Floor J E Lubberman, Jolien Tol, et al.
Cancers|June 10, 2023
Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?Eline L Giraud, Loek A W de Jong, Erik van den Hombergh, et al.
Therapeutic Drug Monitoring|July 27, 2019
Simple and Rapid Quantification of the Multi-Enzyme Targeting Antifolate Pemetrexed in Human PlasmaErik van den Hombergh, Nikki de Rouw, Michel van den Heuvel, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2026
Mapping drug-drug interactions in pharmacokinetic boosting of olaparibJoanneke K Overbeek, Sarmad M S Naoom, Laura Nijboer, et al.
Clinical Pharmacokinetics|June 15, 2016
A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer PatientsNielka P van Erp, Carla M van Herpen, Djoeke de Wit, et al.
British Journal of Clinical Pharmacology|September 30, 2023
Results of the first international quality control programme for oral targeted oncolyticsEline L Giraud, Lindsey M H Te Brake, Erik C A van den Hombergh, et al.
Pageof 11